| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
Januar 2009 - 73 Präparate |
|
| | FI | | | Leucovorin-Teva 50 mg / 5 ml | Ampulle(n) | 10.90 | 28.25 | 10% | | Infusionslösung: Acidum Folinicum 50mg / 5ml | Teva Pharma AG | B / SL / SG | FB | | G | |
| | FI | | | Leucovorin-Teva 100 mg / 10 ml | Ampulle(n) | 21.80 | 40.10 | 10% | | Infusionslösung: Acidum Folinicum 100mg / 10ml | Teva Pharma AG | B / SL / SG | FB | | G | |
| | FI | | | Leucovorin-Teva 300 mg / 30 ml | Ampulle(n) | 65.40 | 87.55 | 10% | | Infusionslösung: Acidum Folinicum 300mg / 30ml | Teva Pharma AG | B / SL / SG | FB | | G | |
| | FI | | | Leucovorin-Teva 500 mg / 50 ml | Ampulle(n) | 109.00 | 134.95 | 10% | | Infusionslösung: Acidum Folinicum 500mg / 50ml | Teva Pharma AG | ● B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 0,5 mg oro | 28 Tablette(n) | 7.64 | 17.40 | 10% | | Schmelztabletten: Risperidonum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 1 mg oro | 28 Tablette(n) | 12.82 | 30.15 | 10% | | Schmelztabletten: Risperidonum 1 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 2 mg oro | 28 Tablette(n) | 21.23 | 39.20 | 10% | | Schmelztabletten: Risperidonum 2 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 3 mg oro | 28 Tablette(n) | 30.75 | 49.45 | 10% | | Schmelztabletten: Risperidonum 3 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 4 mg oro | 28 Tablette(n) | 37.49 | 56.55 | 10% | | Schmelztabletten: Risperidonum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Anastrozol-Teva | 30 Tablette(n) | 55.42 | 76.65 | 10% | | Filmtabletten: Anastrozolum 1 mg | Teva Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Anastrozol-Teva | 100 Tablette(n) | 182.48 | 214.80 | 10% | | Filmtabletten: Anastrozolum 1 mg | Teva Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 0.5 mg | 20 Tablette(n) | 4.31 | 14.00 | 10% | | Filmtabletten: Risperidonum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 0.5 mg | 60 Tablette(n) | 10.99 | 28.35 | 10% | | Filmtabletten: Risperidonum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 1 mg | 20 Tablette(n) | 7.94 | 25.15 | 10% | | Filmtabletten: Risperidonum 1 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 1 mg | 60 Tablette(n) | 19.86 | 38.00 | 10% | | Filmtabletten: Risperidonum 1 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 2 mg ‐ F | 20 Tablette(n) | 13.02 | 30.75 | 10% | | Filmtabletten: Risperidonum 2 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 2 mg ‐ F | 60 Tablette(n) | 32.86 | 52.15 | 10% | | Filmtabletten: Risperidonum 2 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 3 mg | 20 Tablette(n) | 18.66 | 37.00 | 10% | | Filmtabletten: Risperidonum 3 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 3 mg | 60 Tablette(n) | 48.63 | 69.30 | 10% | | Filmtabletten: Risperidonum 3 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 4 mg | 20 Tablette(n) | 17.75 | 36.30 | 10% | | Filmtabletten: Risperidonum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 4 mg | 60 Tablette(n) | 53.23 | 74.70 | 10% | | Filmtabletten: Risperidonum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Valacivir-Mepha 500 mg | 10 Tablette(n) | 11.11 | 28.50 | 10% | | Filmtabletten: Valaciclovirum 500 mg | Mepha Pharma AG | ● A / SL / SG | FB | | G | |
| | FI | PI | | Valacivir-Mepha 500 mg | 30 Tablette(n) | 33.25 | 52.55 | 10% | | Filmtabletten: Valaciclovirum 500 mg | Mepha Pharma AG | ● A / SL / SG | FB | | G | |
| | FI | PI | | Valacivir-Mepha 500 mg | 42 Tablette(n) | 44.93 | 65.30 | 10% | | Filmtabletten: Valaciclovirum 500 mg | Mepha Pharma AG | ● A / SL / SG | FB | | G | |
L | | FI | PI | | Valacivir-Mepha 500 mg | 90 Tablette(n) | 84.65 | 108.75 | 10% | | Filmtabletten: Valaciclovirum 500 mg | Mepha Pharma AG | ● A / SL / SG | FB | | G | |
| | FI | PI | | Allopurinol-Mepha 100 mg | 50 Tablette(n) | 2.59 | 12.05 | 10% | | Tabletten: Allopurinolum 100 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Allopurinol-Mepha 100 mg | 100 | 4.55 | 14.20 | 10% | | Tabletten: Allopurinolum 100 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Allopurinol-Mepha 300 mg | 30 Tablette(n) | 3.74 | 13.30 | 10% | | Tabletten: Allopurinolum 300 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Allopurinol-Mepha 300 mg | 100 | 10.49 | 27.80 | 10% | | Tabletten: Allopurinolum 300 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Alendronat Zentiva | 4 | 15.00 | 32.85 | 10% | | Wochentabletten: Acidum Alendronicum 70 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| | FI | PI | | Alendronat Zentiva | 12 | 43.39 | 63.90 | 10% | | Wochentabletten: Acidum Alendronicum 70 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 1 mg/ml | 30 ml | 10.72 | 28.05 | 10% | | Lösung (oral): Risperidonum 1 mg/ml | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | FI | PI | | Risperidon-Mepha 1 mg/ml | 100 ml | 32.71 | 52.00 | 10% | | Lösung (oral): Risperidonum 1 mg/ml | Mepha Pharma AG | B / SL / SG | FB | | G | |
L | | FI | PI | | Inovelon 200 mg | 60 Tablette(n) | 42.05 | 62.15 | 10% | | Filmtabletten: Rufinamidum 200 mg | Eisai Pharma AG | B / SL | FB | | G | |
L | | FI | PI | | Inovelon 400 mg | 100 Tablette(n) | 135.41 | 163.70 | 10% | | Filmtabletten: Rufinamidum 400 mg | Eisai Pharma AG | B / SL | FB | | G | |
L | | FI | | I/B | Varitect CP | Vial(s) à 125 IE | 136.61 | 165.00 | 10% | | Lösung zur intravenösen Injektion: Immunoglobulinum Humanum Varicellae 25 u.I. Corresp. Proteina Plasmatis Humani 50 mg ex illo Immunoglobulinum Humanum Normale (Igg1: ca. 62 %, Igg2: ca. 33 %, Igg3: ca. 3 %, Igg4: ca. 2 %) 96 %/ml | Biotest (Schweiz) AG | B / SL | FB | | G | |
L | | FI | | I/B | Varitect CP | 500 IE | 514.95 | 576.45 | 10% | | Lösung zur intravenösen Injektion: Immunoglobulinum Humanum Varicellae 25 u.I. Corresp. Proteina Plasmatis Humani 50 mg ex illo Immunoglobulinum Humanum Normale (Igg1: ca. 62 %, Igg2: ca. 33 %, Igg3: ca. 3 %, Igg4: ca. 2 %) 96 %/ml | Biotest (Schweiz) AG | B / SL | FB | | G | |
L | | FI | | I/B | Varitect CP | 1250 IE | 1203.80 | 1325.60 | 10% | | Lösung zur intravenösen Injektion: Immunoglobulinum Humanum Varicellae 25 u.I. Corresp. Proteina Plasmatis Humani 50 mg ex illo Immunoglobulinum Humanum Normale (Igg1: ca. 62 %, Igg2: ca. 33 %, Igg3: ca. 3 %, Igg4: ca. 2 %) 96 %/ml | Biotest (Schweiz) AG | B / SL | FB | | G | |
| | FI | | | Leucovorin-Teva 200 mg / 20 ml | Ampulle(n) | PA | PA | k.A. | | Infusionslösung: Acidum Folinicum 200mg / 20ml | Teva Pharma AG | B | FB | | G | |
| | | PI | Ph | Sidroga Beruhigungstee | 20 x 2 g | PA | PA | k.A. | | Geschnittene Kräuter: Passiflorae Herba 2 g | Sidroga AG | E | FB | | G | |
| | FI | PI | | Chlorhexamed Gel 1% | 50 g | PA | PA | k.A. | | Gel: Chlorhexidini Digluconas 10 mg | Haleon Schweiz AG | D / LPPV | FB | | G | |
| | FI | PI | | Inovelon 100 mg | 10 Tablette(n) | 11.74 | 25.75 | k.A. | | Filmtabletten: Rufinamidum 100 mg | Eisai Pharma AG | B | FB | | G | |
| | FI | PI | | Inovelon 200 mg | 50 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Rufinamidum 200 mg | Eisai Pharma AG | B | FB | | G | |
| | FI | PI | | Inovelon 400 mg | 50 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Rufinamidum 400 mg | Eisai Pharma AG | B | FB | | G | |
| | FI | PI | | Inovelon 400 mg | 60 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Rufinamidum 400 mg | Eisai Pharma AG | B | FB | | G | |
| | FI | PI | | Inovelon 400 mg | 200 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Rufinamidum 400 mg | Eisai Pharma AG | B | FB | | G | |
| | FI | PI | | Valacivir-Mepha 1000 mg | 10 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Valaciclovirum 1 g | Mepha Pharma AG | A | FB | | G | |
| | FI | PI | | Valacivir-Mepha 1000 mg | 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Valaciclovirum 1 g | Mepha Pharma AG | A | FB | | G | |
| | FI | PI | | Valacivir-Mepha 1000 mg | 30 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Valaciclovirum 1 g | Mepha Pharma AG | A | FB | | G | |
| | | PI | Ph | Sidroga Hals- und Rachentee | 20 x 2.5 g | PA | PA | k.A. | | Arzneitee: Salviae Officinalis Folium 2.5 mg | Sidroga AG | E / LPPV | FB | | G | |
| | FI | PI | | Calciumgluconat 2.5% AApot | Flasche(n) | PA | PA | k.A. | | Hydrogel: Calcii Gluconas 25 mg | Armeeapotheke | B | FB | | G | |
| | FI | PI | | Calciumgluconat 2.5% AApot | | PA | PA | k.A. | | Hydrogel: Calcii Gluconas 25 mg | Armeeapotheke | D | FB | | G | |
| | FI | | | Soluprick Negativ- Kontrolle | Flasche(n) | PA | PA | k.A. | | | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick Positiv- Kontrolle | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Histamini Dihydrochloridum 10 mg/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Apis mellifera 10 ug/ml | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Apis Melliferae Venenum 10 µg/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Apis mellifera 100 ug/ml | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Apis Melliferae Venenum 100 µg/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Apis mellifera 300 ug/ml | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Apis Melliferae Venenum 300 µg/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Artemisia vulgaris | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Pollinis Allergeni Extractum (Artemisia Vulgaris) 10 U/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Betula verrucosa | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Pollinis Allergeni Extractum (Betula Pendula) 10 U/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Canis familiaris | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Canis Pilorum Allergeni Extractum (Canis Lupus Familiaris) 10 U/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Dermatophagoides farinae | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Acari Allergeni Extractum (Dermatophagoides Farinae) 10 U/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Dermatophagoides pteronyssinus | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Acari Allergeni Extractum (Dermatophagoides Pteronyssinus) 10 U/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Felis domesticus | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Cati Pilorum Allergeni Extractum (Felis Domesticus) 10 U/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Phleum pratense | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Pollinis Allergeni Extractum (Phleum Pratense) 10 U/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Vespula spp. 10 ug/ml | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Vespulae spp. Venenum 10 µg/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Vespula spp. 100 ug/ml | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Vespulae spp. Venenum 100 µg/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Soluprick SQ Vespula spp. 300 ug/ml | Flasche(n) | PA | PA | k.A. | | Pricktestlösung: Vespulae spp. Venenum 300 µg/ml | ALK-Abelló AG | A | FB | | G | |
| | FI | | | Doxorubicin Sandoz 10 mg / 5 ml | Durchstechflasche(n) | 13.85 | 28.15 | k.A. | | Injektionslösung: Doxorubicini Hydrochloridum 10mg / 5ml | Sandoz Pharmaceuticals AG | A | FB | | G | |
| | FI | | | Doxorubicin Sandoz 50 mg / 25 ml | Durchstechflasche(n) | 61.85 | 87.40 | k.A. | | Injektionslösung: Doxorubicini Hydrochloridum 50mg / 25ml | Sandoz Pharmaceuticals AG | A | FB | | G | |
| | FI | | | Doxorubicin Sandoz 100 mg / 50 ml | Durchstechflasche(n) | 121.22 | 155.55 | k.A. | | Injektionslösung: Doxorubicini Hydrochloridum 100mg / 50ml | Sandoz Pharmaceuticals AG | A | FB | | G | |
| | FI | | | Doxorubicin Sandoz 200 mg / 100 ml | Durchstechflasche(n) | 151.10 | 194.30 | k.A. | | Injektionslösung: Doxorubicini Hydrochloridum 200mg / 100ml | Sandoz Pharmaceuticals AG | A | FB | | G | |
| | FI | PI | | Chlorhexamed forte 0.2% | 300 ml | PA | PA | k.A. | | | Haleon Schweiz AG | D | FB | | G | |
| | FI | PI | | Chlorhexamed forte 0.2% | 600 ml | PA | PA | k.A. | | | Haleon Schweiz AG | D | FB | | G | |